comparemela.com

Latest Breaking News On - Odysseas manesiotis - Page 2 : comparemela.com

SARTORIUS VORZUEGE : Berenberg reiterates its Buy rating

In his latest research note, analyst Odysseas Manesiotis confirms his positive recommendation. The broker Berenberg is keeping its Buy rating. The target price remains set at EUR 346.

Odysseas-manesiotis

STRATEC BIOMEDICAL SYSTEMS AG : Berenberg sticks Neutral -March 28, 2024 at 07:26 am EDT

Odysseas Manesiotis from Berenberg retains his Neutral opinion on the stock. The target price continues to be set at EUR 43.

Odysseas-manesiotis

Berenberg raises target for Sartorius to 346 euros - 'Buy'

The private bank Berenberg has raised the target price for Sartorius from 310 to 346 euros and left the rating at Buy. In a study published on Friday, analyst Odysseas Manesiotis justified his new.

Hamburg
Germany
Odysseas-manesiotis
Markets

SARTORIUS VORZUEGE : Berenberg gives a Buy rating -February 16, 2024 at 02:43 am EST

In a research note, Berenberg analyst Odysseas Manesiotis has maintained his recommendation on the stock with a Buy rating. The target price has been lifted and is now set at EUR 346 compared to EUR.

Odysseas-manesiotis
Markets

QIAGEN NV : Berenberg reiterates its Buy rating -February 16, 2024 at 02:56 am EST

Already positive, the research from Berenberg and its analyst Odysseas Manesiotis still consider the stock as a Buy opportunity. The target price remains set at EUR 54.20.

Odysseas-manesiotis
Markets

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.